- Home
- GLV vs HYPR Comparison
GLV vs HYPR Comparison
Compare GLV & HYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GLV | HYPR |
|---|---|---|
| Founded | N/A | 2014 |
| Country | United States | United States |
| Employees | N/A | 102 |
| Industry | Finance/Investors Services | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 80.0M | 83.2M |
| IPO Year | 2004 | 2021 |
Fundamental Metrics
Financial Performance| Metric | GLV | HYPR |
|---|---|---|
| Price | $5.89 | $0.79 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $1.59 |
| AVG Volume (30 Days) | 32.3K | ★ 382.5K |
| Earning Date | 01-01-0001 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 23.21 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $13,563,000.00 |
| Revenue This Year | N/A | $50.75 |
| Revenue Next Year | N/A | $29.71 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 5.22 |
| 52 Week Low | $5.77 | $0.77 |
| 52 Week High | $6.65 | $2.22 |
Technical Indicators
Market Signals| Indicator | GLV | HYPR |
|---|---|---|
| Relative Strength Index (RSI) | 31.76 | 33.35 |
| Support Level | $5.84 | N/A |
| Resistance Level | $6.37 | $1.39 |
| Average True Range (ATR) | 0.06 | 0.03 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 10.71 | 27.99 |
Price Performance
Historical ComparisonAbout GLV Clough Global Dividend and Income Fund of beneficial interest
Clough Global Dividend and Income Fund is a closed-ended investment management company. The fund's investment objective is to provide a high level of total return. It invests in equity and debt securities in both U.S. and non-U.S. markets of companies of any market capitalization.
About HYPR Hyperfine Inc.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales, which consist of sales from subscriptions of bundled devices, maintenance, and software. The company is in the health technology business with a mission to revolutionize patient care globally through accessible, affordable, clinically relevant artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. The Company operates in one business segment, which includes all activities related to production, supply, service, and commercialization of the Swoop system.